NCT00362973View on ClinicalTrials.gov

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2009

Conditions
Breast Cancer
Interventions
OTHER

laboratory biomarker analysis

PROCEDURE

needle biopsy

PROCEDURE

positron emission tomography

PROCEDURE

radionuclide imaging

RADIATION

fludeoxyglucose F 18

Trial Locations (2)

98109-1023

Seattle Cancer Care Alliance, Seattle

98109-1024

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT00362973 - PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer | Biotech Hunter | Biotech Hunter